Search Result "PD-1 inhibitor"


Review Article

Inhibitory Effect of PD-1/PD-L1 and Blockade Immunotherapy inLeukemia

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 25 Issue: 9 Year: 2022 Page: 1399-1410
Author(s): Kai Xing,Pan Zhou,Jiaojiao Li,Miao Liu,Wei Emma Zhang

Systematic Review Article

Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis

Journal: Current Cancer Drug Targets
Volume: 21 Issue: 9 Year: 2021 Page: 794-803
Author(s): Minyong Peng,Shan Li,Hui Xiang,Wen Huang,Weiling Mao,Di Xu

Review Article

Current Medicinal Insights on Synthetic Small Molecules and NaturalOrigin Products as PD-1/PD-L1 Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 23 Issue: 18 Year: 2023 Page: 1765-1781
Author(s): Balak Das Kurmi

Review Article

Research Progress of PD 1/PD L1 Inhibitors in the Treatment ofUrological Tumors

Journal: Current Cancer Drug Targets
Volume: 24 Issue: 11 Year: 2024 Page: 1104-1115
Author(s):

Review Article

Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic

Journal: Current Cancer Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 3-18
Author(s): Feng Gao,Chun Yang

Review Article

Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway

Journal: Current Cancer Therapy Reviews
Volume: 13 Issue: 2 Year: 2017 Page: 120-128
Author(s): Yijun Huang,Hong Zhang

Review Article

PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 39 Year: 2017 Page: 6033-6041
Author(s): Qiaohong Geng,Peifu Jiao,Peng Jin,Gaoxing Su,Jinlong Dong,Bing Yan

Research Article

Occurrence and Severity of Adverse Reactions of Immune CheckpointInhibitors (PD-1 and PD L1) Based on Mordovian Dispensary DataAnalysis

Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 51-56
Author(s): Basheer Marzoog

Review Article

Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14 Issue: 2 Year: 2019 Page: 100-112
Author(s): Spandana R. Kopalli,Tae-Bong Kang,Kwang-Ho Lee,Sushruta Koppula

Review Article

Beyond PD-1/PD-L1 Axis Blockade: New Combination Strategies in Metastatic Melanoma Treatment

Journal: Current Cancer Therapy Reviews
Volume: 15 Issue: 2 Year: 2019 Page: 110-119
Author(s): Emilio Francesco Giunta,Giuseppe Argenziano,Gabriella Brancaccio,Erika Martinelli,Fortunato Ciardiello,Teresa Troiani

Previous   Next

Go To   Results 1 - 1 of 7631

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy